Applied Genetic Technologies Corp financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
14193 Nw 119 Th Terrace, Suite #10, Alachua, FL
State of incorporation
DE
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2022 - Nov 21, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 229 % -55.5%
Debt-to-equity 108 % +120%
Return On Equity -193 % -138%
Return On Assets -92.5 % -70.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.6M shares +57.6%
Common Stock, Shares, Outstanding 67.6M shares +57.8%
Common Stock, Value, Issued 68K USD +58.1%
Weighted Average Number of Shares Outstanding, Basic 64.9M shares +51.6%
Weighted Average Number of Shares Outstanding, Diluted 64.9M shares +51.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 325K USD -35%
Research and Development Expense 50.1M USD +11%
General and Administrative Expense 17.3M USD +14%
Operating Income (Loss) -67.1M USD -12.2%
Nonoperating Income (Expense) -2.9M USD -62.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -70.2M USD -17.9%
Earnings Per Share, Basic -1.42 USD/shares +15.5%
Earnings Per Share, Diluted -1.42 USD/shares +15.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 34.2M USD -62.2%
Assets, Current 37.2M USD -60.1%
Property, Plant and Equipment, Net 4.88M USD +7.34%
Operating Lease, Right-of-Use Asset 2.89M USD -5.53%
Intangible Assets, Net (Excluding Goodwill) 1.54M USD +18.3%
Other Assets, Noncurrent 126K USD +4.13%
Assets 57.3M USD -48.1%
Accounts Payable, Current 4.04M USD +94.1%
Employee-related Liabilities, Current 3.45M USD +19.3%
Liabilities, Current 26.6M USD +22.5%
Operating Lease, Liability, Noncurrent 2.53M USD -21.4%
Other Liabilities, Noncurrent 99K USD -67%
Liabilities 39.7M USD -2.93%
Retained Earnings (Accumulated Deficit) -327M USD -27.4%
Stockholders' Equity Attributable to Parent 17.6M USD -74.6%
Liabilities and Equity 57.3M USD -48.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16M USD -0.63%
Net Cash Provided by (Used in) Financing Activities 7.14M USD +50879%
Net Cash Provided by (Used in) Investing Activities -304K USD -122%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 67.7M shares +57.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.2M USD +36.7%
Deferred Tax Assets, Valuation Allowance 105M USD +24.5%
Deferred Tax Assets, Gross 105M USD +24%
Operating Lease, Liability 4.05M USD -10.7%
Payments to Acquire Property, Plant, and Equipment 183K USD -66.4%
Lessee, Operating Lease, Liability, to be Paid 4.83M USD -14%
Property, Plant and Equipment, Gross 11.9M USD +12.6%
Operating Lease, Liability, Current 1.28M USD +13.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.31M USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.33M USD +13.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 777K USD -27.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 939K USD -21.9%
Deferred Tax Assets, Operating Loss Carryforwards 61.9M USD +40.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 515K USD -42%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 372K USD +2.2%
Deferred Tax Assets, Net of Valuation Allowance 959K USD -8.41%
Interest Expense 2.66M USD +44.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%